APOVIT B-KOMPLEKS FORTE

This brand name is authorized in Estonia.

Active ingredients

The drug APOVIT B-KOMPLEKS FORTE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII X66NSO3N35 - THIAMINE
 

Thiamine pyrophosphate (TPP), the coenzymatic form of thiamine, is involved in two main types of metabolic reactions: decarboxylation of α-ketoacids (e.g. pyruvate, α-ketoglutarate and branched-chain keto acids) and transketolation (e.g. among hexose and pentose phosphates). Therefore, the principal physiological role of thiamine is as a coenzyme in carbohydrate metabolism, where TPP is required for several stages in the breakdown of glucose to provide energy.

 
Read more about Vitamin B1
2
UNII 25X51I8RD4 - NIACINAMIDE
 
Read more about Niacinamide
3
UNII TLM2976OFR - RIBOFLAVIN
 

Riboflavine is phosphorylated to flavine mononucleotide and flavine adenine dinucleotide which act as co-enzymes in the respiratory chain and in oxidative phosphorylation. Riboflavine deficiency presents with ocular symptoms, as well as lesions on the lips and at angles of the mouth.

 
Read more about Riboflavin
4
UNII 568ET80C3D - CALCIUM PANTOTHENATE
 

Pantothenic acid is incorporated into co-enzyme A and is involved in metabolic pathways involving acetylation which includes detoxification of drug molecules and biosynthesis of cholesterol, steroid hormones, mucopolysaccharides and acetylcholine. CoA has an essential function in lipid metabolism.

 
Read more about Pantothenic acid
5
UNII KV2JZ1BI6Z - PYRIDOXINE
 

Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition.

 
Read more about Pyridoxine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A11EA Vitamin B-complex, plain A Alimentary tract and metabolism → A11 Vitamins → A11E Vitamin B-complex, incl. combinations
Discover more medicines within A11EA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1100013

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.